383 related articles for article (PubMed ID: 24888239)
1. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Wakui S; Furusato M; Sasaki S; Muto T; Takahashi H; Masaoka T; Ushigome S
Vet Pathol; 1999 Mar; 36(2):111-6. PubMed ID: 10098638
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Tatematsu M; Lurie AG; Rippey RM; Conran PB; Arai M; Fukushima S; Ito N
Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
5. Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Hagiwara A; Fukushima S; Kitaori M; Shibata M; Ito N
Gan; 1984 Sep; 75(9):763-8. PubMed ID: 6500232
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
[TBL] [Abstract][Full Text] [Related]
7. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
9. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
Ito N; Fukushima S; Shirai T; Nakanishi K
Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
[TBL] [Abstract][Full Text] [Related]
10. Effect of phenacetin and caffeine on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Fukushima S; Shibata M; Shirai T; Ogiso T; Ito N
Gan; 1978 Jun; 69(3):395-400. PubMed ID: 669140
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclophosphamide on rat urinary bladder epithelium treated wtih N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hirose M; Murasaki G; Imaida K; Fukushima S; Ito N
Gan; 1980 Oct; 71(5):729-32. PubMed ID: 7227722
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
[TBL] [Abstract][Full Text] [Related]
13. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
[TBL] [Abstract][Full Text] [Related]
15. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
[TBL] [Abstract][Full Text] [Related]
16. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
[TBL] [Abstract][Full Text] [Related]
17. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
[TBL] [Abstract][Full Text] [Related]
18. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
